Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

Information

• Research Project
• 9791229

• ApplicationId

  9791229

• Core Project Number

• Full Project Number

  272201800024C-0-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  9/21/2018 - 6 years ago

• Project End Date

  9/30/2019 - 5 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2018

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• VAXINE PTY LTD

To support advanced development of platform technologies for the development of a cell culture pandemic influenza vaccine containing adjuvants. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in nonhuman primates, IND enabling GLP repeated dose toxicology, submission of an IND and eventual clinical evaluation.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  2835478

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

• Ed Inst. Type

• Funding ICs

  NIAID:2835478\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  VAXINE PTY LTD

• Organization Department

• Organization DUNS

  750421575

• Organization City

  BEDFORD PARK

• Organization State

• Organization Country

  AUSTRALIA

• Organization Zip Code

  5042

• Organization District

  AUSTRALIA